TY - JOUR
T1 - Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU
T2 - Cardiovascular, endocrine, hematologic, pulmonary, and renal considerations
AU - RNanchal, Ahul
AU - Subramanian, Ram
AU - Karvellas, Constantine J.
AU - Hollenberg, Steven M.
AU - Peppard, William J.
AU - Singbartl, Kai
AU - Truwit, Jonathon
AU - Al-Khafaji, Ali H.
AU - Killian, Alley J.
AU - Alquraini, Mustafa
AU - Alshammari, Khalil
AU - Alshamsi, Fayez
AU - Belley-Cote, Emilie
AU - Cartin-Ceba, Rodrigo
AU - Dionne, Joanna C.
AU - Galusca, Dragos M.
AU - Huang, David T.
AU - Hyzy, Robert C.
AU - Junek, Mats
AU - Kandiah, Prem
AU - Kumar, Gagan
AU - Morgan, Rebecca L.
AU - Morris, Peter E.
AU - Olson, Jody C.
AU - Sieracki, Rita
AU - Steadman, Randolph
AU - Taylor, Beth
AU - Alhazzani, Waleed
N1 - Publisher Copyright:
Copyright © 2020 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
PY - 2020
Y1 - 2020
N2 - Objectives: To develop evidence-based recommendations for clinicians caring for adults with acute or acute on chronic liver failure in the ICU. Design: The guideline panel comprised 29 members with expertise in aspects of care of the critically ill patient with liver failure and/ or methodology. The Society of Critical Care Medicine standard operating procedures manual and conflict-of-interest policy were followed throughout. Teleconferences and electronic-based discussion among the panel, as well as within subgroups, served as an integral part of the guideline development. Setting: The panel was divided into nine subgroups: cardiovascular, hematology, pulmonary, renal, endocrine and nutrition, gastrointestinal, infection, perioperative, and neurology. Interventions: We developed and selected population, intervention, comparison, and outcomes questions according to importance to patients and practicing clinicians. For each population, intervention, comparison, and outcomes question, we conducted a systematic review aiming to identify the best available evidence, statistically summarized the evidence whenever applicable, and assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. We used the evidence to decision framework to facilitate recommendations formulation as strong or conditional. We followed strict criteria to formulate best practice statements. Measurements and Main Results: In this article, we report 29 recommendations (from 30 population, intervention, comparison, and outcomes questions) on the management acute or acute on chronic liver failure in the ICU, related to five groups (cardiovascular, hematology, pulmonary, renal, and endocrine). Overall, six were strong recommendations, 19 were conditional recommendations, four were best-practice statements, and in two instances, the panel did not issue a recommendation due to insufficient evidence. Conclusions: Multidisciplinary international experts were able to formulate evidence-based recommendations for the management acute or acute on chronic liver failure in the ICU, acknowledging that most recommendations were based on low-quality indirect evidence.
AB - Objectives: To develop evidence-based recommendations for clinicians caring for adults with acute or acute on chronic liver failure in the ICU. Design: The guideline panel comprised 29 members with expertise in aspects of care of the critically ill patient with liver failure and/ or methodology. The Society of Critical Care Medicine standard operating procedures manual and conflict-of-interest policy were followed throughout. Teleconferences and electronic-based discussion among the panel, as well as within subgroups, served as an integral part of the guideline development. Setting: The panel was divided into nine subgroups: cardiovascular, hematology, pulmonary, renal, endocrine and nutrition, gastrointestinal, infection, perioperative, and neurology. Interventions: We developed and selected population, intervention, comparison, and outcomes questions according to importance to patients and practicing clinicians. For each population, intervention, comparison, and outcomes question, we conducted a systematic review aiming to identify the best available evidence, statistically summarized the evidence whenever applicable, and assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. We used the evidence to decision framework to facilitate recommendations formulation as strong or conditional. We followed strict criteria to formulate best practice statements. Measurements and Main Results: In this article, we report 29 recommendations (from 30 population, intervention, comparison, and outcomes questions) on the management acute or acute on chronic liver failure in the ICU, related to five groups (cardiovascular, hematology, pulmonary, renal, and endocrine). Overall, six were strong recommendations, 19 were conditional recommendations, four were best-practice statements, and in two instances, the panel did not issue a recommendation due to insufficient evidence. Conclusions: Multidisciplinary international experts were able to formulate evidence-based recommendations for the management acute or acute on chronic liver failure in the ICU, acknowledging that most recommendations were based on low-quality indirect evidence.
KW - Acute liver failure
KW - Acute on chronic liver failure
KW - And Evaluation criteria
KW - Clinical practice guidelines
KW - Development
KW - Evidence-based medicine
KW - Grading of Recommendations Assessment
UR - http://www.scopus.com/inward/record.url?scp=85079359996&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079359996&partnerID=8YFLogxK
U2 - 10.1097/CCM.0000000000004192
DO - 10.1097/CCM.0000000000004192
M3 - Review article
C2 - 32058387
AN - SCOPUS:85079359996
SN - 0090-3493
VL - 48
SP - E173-E191
JO - Critical Care Medicine
JF - Critical Care Medicine
IS - 3
ER -